These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35365114)

  • 1. Dynamics in public perceptions and media coverage during an ongoing outbreak of meningococcal W disease in the Netherlands.
    de Vries M; Claassen L; Te Wierik MJM; Timmermans DRM; Timen A
    BMC Public Health; 2022 Apr; 22(1):633. PubMed ID: 35365114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Information needs during an emerging outbreak of meningococcal W135 disease in the Netherlands: a study among teenagers, their parents and healthcare professionals.
    de Vries M; Çoban FR; Claassen L; Te Wierik MJM; Timmermans DRM; Timen A
    BMC Public Health; 2021 Aug; 21(1):1540. PubMed ID: 34380443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile.
    Graña MG; Cavada G; Vasquez M; Shen J; Maervoet J; Klint J; Gómez JA
    Hum Vaccin Immunother; 2021 Dec; 17(12):5603-5613. PubMed ID: 34890520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study.
    Ohm M; Hahné SJM; van der Ende A; Sanders EAM; Berbers GAM; Ruijs WLM; van Sorge NM; de Melker HE; Knol MJ
    Clin Infect Dis; 2022 Jul; 74(12):2173-2180. PubMed ID: 34525199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningococcal W135 Disease Vaccination Intent, the Netherlands, 2018-2019.
    de Vries M; Claassen L; Te Wierik MJM; Coban F; Wong A; Timmermans DRM; Timen A
    Emerg Infect Dis; 2020 Jul; 26(7):1420-1429. PubMed ID: 32568034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescent and parental decision-making for the MenACWY vaccination: influential predictors and parental-adolescent differences among households in the Netherlands.
    Oostdijk C; Ferreira JA; Ruijs WLM; Mollema L; Van Zoonen K
    BMC Public Health; 2023 May; 23(1):947. PubMed ID: 37231425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential public health impact of a
    Huang L; Snedecor SJ; Balmer P; Srivastava A
    Postgrad Med; 2022 May; 134(4):341-348. PubMed ID: 33615973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inequalities in the risk and prevention of invasive meningococcal disease in the United States - A systematic literature review.
    Begum S; Herrera-Restrepo O; Rolland C; Purushotham S; Andani A; Shah H; Kocaata Z
    Hum Vaccin Immunother; 2024 Dec; 20(1):2406613. PubMed ID: 39373020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine.
    Ruiz Garcia Y; Abitbol V; Pellegrini M; Bekkat-Berkani R; Soumahoro L
    Infect Dis Ther; 2022 Apr; 11(2):639-655. PubMed ID: 34591258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of meningococcal ACWY antibodies across the population in the Netherlands: Two consecutive surveys in 2016/17 and 2020.
    Ohm M; Knol MJ; Vos ERA; Bogaard MJM; van Rooijen DM; Sanders EAM; de Melker HE; van der Klis FRM; Berbers GAM
    Vaccine; 2022 Jan; 40(1):59-66. PubMed ID: 34839991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Need for Optimisation of Immunisation Strategies Targeting Invasive Meningococcal Disease in the Netherlands.
    Bousema JC; Ruitenberg J
    Int J Health Policy Manag; 2015 Sep; 4(11):757-61. PubMed ID: 26673336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling the impact of 4CMenB and MenACWY meningococcal combined vaccination strategies including potential 4CMenB cross-protection: An application to England.
    Beck E; Klint J; Garcia S; Abbing V; Abitbol V; Akerborg O; Argante L; Bekkat-Berkani R; Hogea C; Neine M; Vadivelu K; Whelan J; Meszaros K
    Vaccine; 2020 Nov; 38(47):7558-7568. PubMed ID: 32807531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.
    van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Sanders EAM; Berbers GAM
    Vaccine; 2017 Aug; 35(36):4753-4760. PubMed ID: 28647167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Household decision-making for the MenACWY vaccination: How parents and adolescents deal with an adolescent vaccination decision.
    Oostdijk C; Van Zoonen K; Ruijs WLM; Mollema L
    Vaccine; 2021 Jul; 39(31):4283-4290. PubMed ID: 34172331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of invasive meningococcal disease in university students in England and optimal strategies for protection using MenACWY vaccine.
    Mandal S; Campbell H; Ribeiro S; Gray S; Carr T; White J; Ladhani SN; Ramsay ME
    Vaccine; 2017 Oct; 35(43):5814-5818. PubMed ID: 28928076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world impact and effectiveness of MenACWY-TT.
    Villena R; Kriz P; Tin Tin Htar M; Burman C; Findlow J; Balmer P; Jodar L
    Hum Vaccin Immunother; 2023 Aug; 19(2):2251825. PubMed ID: 37679903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving strategies for meningococcal vaccination in Europe: Overview and key determinants for current and future considerations.
    Martinón-Torres F; Taha MK; Knuf M; Abbing-Karahagopian V; Pellegrini M; Bekkat-Berkani R; Abitbol V
    Pathog Glob Health; 2022 Mar; 116(2):85-98. PubMed ID: 34569453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine in Australian adolescents.
    Si S; Zomer E; Fletcher S; Lee J; Liew D
    Vaccine; 2019 Aug; 37(35):5009-5015. PubMed ID: 31301916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018.
    Knol MJ; Ruijs WL; Antonise-Kamp L; de Melker HE; van der Ende A
    Euro Surveill; 2018 Apr; 23(16):. PubMed ID: 29692317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parental awareness of Meningococcal B vaccines and willingness to vaccinate their teens.
    Basta NE; Becker AB; Li Q; Nederhoff D
    Vaccine; 2019 Jan; 37(4):670-676. PubMed ID: 30587431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.